Description

Imbruvica (Ibrutinib) For Sale in USA

Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, which is used to treat various blood cancers and also a serious complication of allogeneic stem cell transplants called chronic graft versus host disease (cGVHD).

Ibrutinib helps to slow down how quickly certain blood cancers progress by working against cancerous B cells, a type of white blood cell. It does this by blocking Bruton’s tyrosine kinase (BTK) signaling. BTK is a protein found on B cells that instructs B cells to remain alive and multiply. Ibrutinib also blocks the activity of a similar protein called interleukin-2-inducible T-cell kinase (ITK). It’s thought that this action and it’s ability to block BTK helps in cGVHD. Imbruvica (Ibrutinib) For Sale in USA

Ibrutinib was first approved by the US Food and Drug Administration (FDA) in 2013.

What is ibrutinib used for?

Ibrutinib is a prescription medicine used to treat :

• Adults with mantle cell lymphoma (MCL) who have received at least one prior treatment.
• Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL).
• Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion.
• Adults with Waldenström’s macroglobulinemia (WM).
• Adults with marginal zone lymphoma (MZL) who require a medicine by mouth or injection (systemic therapy) and have received a certain type of prior treatment.
• Adults and children 1 year of age and older with chronic graft versus host disease (cGVHD) after failure of 1 or more lines of systemic therapy.

It is not known if it is safe and effective in children under 1 year of age.

How should I take ibrutinib?

• Take ibrutinib exactly as your healthcare provider tells you to take it.
• Take 1 time a day at about the same time each day.

How should I take ibrutinib tablets and capsules

• Swallow ibrutinib capsules or tablets whole with a glass of water.
• Do not open, break, or chew the capsules.
• Do not cut, crush, or chew the tablets.